Premium
Olanzapine associated weight gain, Hyperglycemia and Neuroleptic Malignant Syndrome: case report
Author(s) -
Malyuk Rhonda,
Gibson Bruce,
Procyshyn Ric M.,
Kang Nirmal
Publication year - 2002
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/gps.596
Subject(s) - olanzapine , neuroleptic malignant syndrome , weight gain , medicine , glycemic , diabetes mellitus , schizophrenia (object oriented programming) , pediatrics , psychiatry , body weight , endocrinology
We describe here a case of olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome in a 64 year‐old woman with a significant medical history. Eighteen weeks after initiating olanzapine, Mrs X lost glycemic control, exhibited signs and symptoms consistent with neuroleptic malignant syndrome and gained 8.9 kg. We suggest that utilization of olanzapine in the less medically stable geriatric patient be implemented with vigilant monitoring for such complications mentioned above. Copyright © 2002 John Wiley & Sons, Ltd.